Special Session V “Evolution of the BioXp™ – The DNA writing platform, compressing Design-Build-Test cycle”
14th November 2017, 10:30 – 11:30, Saal 3
The evolution of the BioXp system from simple gene assembly and cloning through the rapid development of Protein Engineering to feed your assay. Our subscriber base is changing the approach to building variants libraries. A discussion on how they utilize the BioXp to remove the manual effort typically associated with introducing changes to your wildtype or parent sequence. Exploring customer results of this rapid, hands-free approach to building rationally designed or mutational variants. The BioXp 3200 removes the typical design, planning, logistics and benchwork associated with engineering your sequences of interest.
Senior Director of Field Applications
Mr. Riedmuller brings 2 decades of leadership experience in developing automated solutions for molecular / synthetic biology. From 1998 to 2004 he conceptualized and built automation systems for ultra-high throughput Sanger sequencing at The Institute for Genomic Research and the J. Craig Venter Joint Technology Center. In 2004 he transitioned to the commercial side of laboratory automation, joining Hudson Robotics, Inc. in Springfield NJ. At Hudson Robotics, he managed the design and build of several firsts for synthetic biology automation. In 2015, Mr. Riedmuller joined Synthetic Genomics as their Senior Director of Field Applications. Specializing in the BioXp Platform, he and his team work with the synbio market to implement existing technology and develop new high value capability for the BioXp platform with the goal of greatly reducing the Design, Build, Test cycle.